CopyMark Law Group
4.9/5
Drawing for ULTRAHITMAB

USPTO serial 79441828

ULTRAHITMAB

Reviewed by CopyMark Law Group

Reg. 8481279Status 700Registered
Filing date
Status date
Registration date
Oct 6, 2026
Examiner
FITZSIMONS, MICHAEL R
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ULTRAHITMAB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael S. Hargis

Michael S. Hargis Stites & Harbison, PLLC250 W. Main Street, Suite 2300Lexington, KY 40507United States

Goods and services

ClassDescriptionStatusFirst use
005Vaccines; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of kidney disease; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of respiratory system disorders; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of infectious diseases, pain, cancer and tumors; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of blood disorders, metabolic and neurological disorders; Biological preparations for medical purposes, namely, biological reagents for medical purposes; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; Biological preparations for medical purposes for the prevention and treatment of respiratory system disorders; Biological preparations for medical purposes for the prevention and treatment of immune system related diseases and disorders; Biological preparations for medical purposes for the prevention and treatment of infectious diseases, pain, cancer and tumors; Biological preparations for medical purposes for the prevention and treatment of blood disorders, metabolic and neurological disorders; Antiallergic medicines for human purposes; Medicines for human purposes, namely, pharmaceutical preparations for the treatment of cancer and antibiotics; Medicines for human purposes for the prevention and treatment of respiratory system disorders; Medicines for human purposes for the prevention and treatment of immune system related diseases and disorders; Medicines for human purposes for the prevention and treatment of infectious diseases, pain, cancer and tumors; Medicines for human purposes for the prevention and treatment of blood disorders, metabolic and neurological disorders; Diagnostic preparations for medical purposes; Dietetic preparations adapted for medical use; Dietetic foods and beverages adapted for medical use; Protein supplements for animals; Absorbent cotton for medical purposesACTIVE—
035Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; Wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; Marketing services; Commercial administration of the licensing of the goods and services of others; Presentation of goods on communication media, for retail purposes in the nature of computerized online ordering services in the field of pharmaceutical, veterinary and sanitary preparations and medical supplies; Presentation of goods on communication media, for retail purposes, namely, providing television home shopping services in the field of general consumer merchandise; Advertising servicesACTIVE—
042Technological research in the field of pharmaceuticals; Technological research in the fields of genetics, genetic engineering, molecular biology and cellular immunology; Technological research in the field of medicine; Research in the field of genetic modification technology; chemical analysis; Chemistry services in the nature of chemist services; Chemistry services, namely, consultation, research and advice; Medical research; laboratory services for biomanufacturing; Scientific research in the nature of clinical trials for others; Computer programming; Providing online non-downloadable computer software for scientific analysis of pharmacological effects of medicines; Rental of scientific microscopesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 6, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 6, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 18, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 18, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 13, 2026GPNXNOTIFICATION PROCESSED BY IB—
Aug 12, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 29, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 29, 2026OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 17, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 16, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 16, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 16, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 21, 2026RFNTREFUSAL PROCESSED BY IB—
May 7, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 6, 2026RFRRREFUSAL PROCESSED BY MPU—
Mar 25, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 24, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2026DOCKASSIGNED TO EXAMINER—
Jan 27, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 27, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 22, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance